Observed Sex Differences in Cardiometabolic Indices in Patients on Antipsychotics

• DOI: 10.4088/pcc.19m02493
• Publication Date: 2021-05-05T15:22:17Z
• Authors: Mark E. Schneiderhan; Xuan Li
• Keywords: Dyslipidemia; Glycated hemoglobin

Objective: To define sex differences in cardiometabolic indice changes over 12 months patients on antipsychotics and to describe treatment complexity, interventions, patient satisfaction of pharmacist comprehensive medication management (CMM) services. Methods: Secondary analyses time effect–associated indices within between study groups were done at baseline months. Each group consisted 60 subjects who received full CMM services (PCS) either modified or no (NCS). Pharmacist are a team-based practice providing direct care. Results: Significant mean change score observed from the combined PCS NCS subjects. Compared men, women had greater body weight (P = .003) waist measurement .02) reductions increased serum level high-density lipoproteins < .001). In contrast, men systolic .001) diastolic .005) blood pressure levels, more hypertension diagnoses .01), less dyslipidemia compared for glycated hemoglobin (HgbA1c) (women: −0.33%, P low-density lipoprotein (men: −21.63 mg/dL, .04) women, significant reduction HgbA1c percentages (−0.46%) (0.28%) was A higher percentage (62%, n 28/45) (38%, 17/45) continued receive Satisfaction survey results positively favored services; however, response rate only 25% (n 18/72). Conclusions: Women appear likely keep follow-up visits, return surveys, reduce abdominal weight, improve both lipid levels satisfied overall with Recognition can promote personalized patient-centered care approach among prescribed antipsychotics. Trial registration: ClinicalTrials.gov identifier: NCT02029989